Hosted on MSN1h
Therapeutic approach to treat virus-induced lung failure for severe COVID-19 shows promise in clinical trial
open-label, controlled, phase 2 trial" has been published in eClinicalMedicine. The physiological role of FasL is to keep ...
News246h
Blue Label picks up debt claims against Cell C for R450m, inks deal for shares
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 ...
Moneyweb11h
BLUE LABEL TELECOMS LIMITED – Acquisition of Shares and Debt Claim against Cell C from Gramercy
Acquisition of Shares and Debt Claim against Cell C from Gramercy ...
Johnson & Johnson: Tracking Well Above The Industry
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
Expensive phones are your carrier's golden handcuffs
Finding financial freedom might mean forgoing that hot new flagship device for something a little simpler. Here's how to save ...
Targeted Oncology1d
Elraglusib Gains FDA Rare Pediatric Disease Designation in Ewing Sarcoma
Elraglusib is undergoing investigation in an open-label, multicenter, phase 1/2 trial for the treatment of patients with ...
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
eLife2d
Mistargeted retinal axons form synaptically segregated subcircuits in the visual thalamus of albino mice
Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, USA ...
How immune cells 'sniff out' pathogens: Signaling study could speed up the search for new drugs
Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...
E&E2d
It’s not ‘real’ meat, but it’s causing real fights in Congress
He is a lead sponsor of the “Fair and Accurate Ingredient Representation on Labels (FAIR Labels) Act,” S. 3693, which would ...
Abbisko: Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
The MANEUVER study met the primary endpoint with an objective response rate (ORR) at week 25 of 54.0% compared with 3.2% for placebo (p- Statistically significant ...